Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:21 PM ET 10-Q
Financial Results CSB Financial Inc. CSBA

CSB Financial Q3 2026 Results: Net Loss of $119K

CSB Financial Inc. completed its mutual-to-stock conversion in 2026, raising $12.1 million in net proceeds and issuing 1,402,935 shares. For the nine months ended September 30, 2026, net income was $136,612, down from $325,585 in the prior year, primarily due to a $375,000 one-time charitable contribution related to the conversion.

Key figure
Net loss $119K
5:21 PM ET 10-Q
Financial Results CoJax Oil & Gas Corp CJAX

CoJax Oil & Gas Q3 2026 Results: Turns Profitable, Net Income $2.9K

CoJax Oil & Gas Corp reported a net income of $2,895 for the quarter ended September 30, 2026, a significant improvement from a net loss of $157,705 in the prior year period. Despite achieving profitability in the last two quarters, management expressed substantial doubt about the company's ability to continue as a going concern due to insufficient profits to support business expansion.

Key figure
Net income $2.9K
5:20 PM ET 8-K
Executive Compensation Dolby Laboratories, Inc. DLB

Dolby Laboratories Executive Compensation

Dolby Laboratories adopted the 2027 Executive Bonus Plan, a cash-based incentive program where CEO Marc Whitten is eligible for a target bonus of 100% of his base salary. The company also approved a new Executive Severance Policy for senior leadership, providing standardized cash severance and benefits for qualified terminations outside of a change-in-control period.

Term
fiscal 2027
5:20 PM ET Form 4
Insider Selling PG&E Corp PCG

PG&E Insider Mark E. Ferguson III Sells $115K of Stock

Mark E. Ferguson III sold 8,675 shares of PG&E Corp at $13.22 a share, worth $115K in total on Nov 11, 2026. Shares held after the trade: 2,000 (-81.3%).

Value
$115K
Shares
8,675
Price
$13.22
Holding change
-81.3%
Trade date
Nov 11, 2026
5:20 PM ET 10-Q
Financial Results Enhanced Group Inc. ENHA

Enhanced Group Q3 2026 Results: Net Loss of $13.5M, Loss Widens

Enhanced Group Inc. is an emerging growth company focused on enhancement-based athletic competition and the Live Enhanced platform. The filing highlights significant risks including a limited operating history, minimal revenues, and a need for additional capital to continue as a going concern following its recent business combination.

Key figure
Net loss $13.5M
5:20 PM ET 8-K
Other 8-K Filing Panamera Holdings Corp PHCI

Panamera Holdings Other 8-K Filing

Panamera Holdings Corp announced that its previously issued financial statements for the fiscal year ended July 31, 2025, can no longer be relied upon. The non-reliance is due to an unreported employment agreement and a resulting lawsuit that impacted the company's financial reporting. The company is currently in the process of restating these financial statements and plans to file an amended Annual Report on Form 10-K as soon as practicable.

5:19 PM ET 8-K
Financial Results Cingulate Inc. CING

Cingulate Financial Results

Cingulate reported Q3 2026 financial results, highlighting a cash position of $23.2 million and progress on its CTx-1301 NDA resubmission. The company has substantially completed manufacturing work to address FDA CMC requests and expects to resubmit the NDA between December 2026 and January 2027. Additionally, the company added Maxim Group LLC as a sales agent to its existing $100 million ATM equity offering program.

Term
Q3 2026

“With the manufacturing work substantially complete, we are now finalizing the data and documentation needed to resubmit the NDA for CTx-1301, and we expect to do so by January 2027, potentially sooner.”

Shane J. Schaffer, Chairman and CEO

“Importantly, the FDA’s Complete Response Letter did not raise any concerns about the clinical safety or efficacy of CTx-1301. We thank our shareholders for their patience and continued support as we work to bring this treatment to patients with ADHD.”

Shane J. Schaffer, Chairman and CEO
5:19 PM ET 10-Q
Financial Results Amaze Holdings, Inc. AMZE

Amaze Holdings Q3 2026 Results: Net Loss of $22.2M, Loss Widens

Amaze Holdings, Inc. reported a significant net loss of $32.3 million for the nine months ended September 30, 2026, primarily driven by a $17.7 million impairment of intangible assets. Revenues declined sharply to $0.47 million in the third quarter compared to $1.25 million in the prior year period, while the company's stockholders' equity shifted from a surplus of $9.8 million to a deficit of $8.2 million.

Key figure
Net loss $22.2M
5:18 PM ET 10-K
Financial Results Edgewell Personal Care Co EPC ▶ Call

Edgewell Personal Care FY 2026 Results: Net Loss of $51.7M

Edgewell Personal Care Co. is focused on its 'Sustainable Care' strategy, targeting reductions in petroleum-based plastics, greenhouse gas emissions, and waste diversion. The company reported approximately 6,500 employees as of September 30, 2026, and continues to manage significant regulatory compliance obligations under the FDA, CPSC, TSCA, and REACH frameworks.

Key figure
Net loss $51.7M
5:18 PM ET 8-K12B
Other 8-K Filing Versa Bancorp VRSA

Versa Bancorp Other 8-K Filing

VersaBank completed a corporate reorganization to establish Versa Bancorp, a Delaware corporation, as its new U.S. bank holding company. Each outstanding common share of VersaBank was exchanged for one share of Versa Bancorp common stock, which will trade on Nasdaq and the TSX under the new ticker 'VRSA' starting around November 17, 2026.

5:18 PM ET 10-Q
Financial Results Pasithea Therapeutics Corp. KTTA

Pasithea Therapeutics Q3 2026 Results: Net Loss of $6.58M, Loss Widens

Pasithea Therapeutics Corp. reported a net loss of $14.7 million for the nine months ended September 30, 2026, driven by a significant increase in research and development expenses to $11.1 million. The company maintained a cash position of $41.2 million as of the end of the period, down from $55.2 million at the start of the year.

Key figure
Net loss $6.58M
5:18 PM ET 10-Q
Financial Results Health In Tech, Inc. HIT

Health In Tech Q3 2026 Results: Net Loss of $7.07M

For the nine months ended September 30, 2026, Health In Tech, Inc. reported total revenues of $23.4 million, a decrease from $25.8 million in the prior year period. The company experienced a significant shift in its financial position, moving from a retained earnings balance of $5.2 million at the end of 2025 to an accumulated deficit of $5.9 million as of September 30, 2026.

Key figure
Net loss $7.07M
5:18 PM ET 8-K
Nasdaq/NYSE Compliance Notice Flux Power Holdings, Inc. FLUX

Flux Power Holdings Nasdaq/NYSE Compliance Notice

Flux Power Holdings received a deficiency notice from Nasdaq on November 9, 2026, for failing to maintain the minimum $2.5 million stockholders' equity requirement. The company has until December 24, 2026, to submit a plan to regain compliance and is also working to meet an extended December 4 deadline for a $4.0 million equity raise required by its lender, Gibraltar Business Capital.

Counterparty
Nasdaq
Term
45 days
5:18 PM ET Form 4
Insider Selling Globalstar, Inc. GSAT

Globalstar VP, Finance & Operations Timothy Evan Taylor Sells $11.2M of Stock

Timothy Evan Taylor, VP, Finance & Operations, sold 129,996 shares of Globalstar, Inc. at $86.16 to $86.38 a share (average $86.29) in 3 transactions, worth $11.2M in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 80,244 (-52.9%).

Value
$11.2M
Shares
129,996
Average price
$86.29
Role
VP, Finance & Operations
Holding change
-52.9%
Trade date
Nov 11, 2026 to Nov 12, 2026
5:18 PM ET 10-Q
Financial Results Nuo Therapeutics, Inc. AURX

Nuo Therapeutics Q3 2026 Results: Net Loss of $425K, Loss Narrows

Nuo Therapeutics reported a significant revenue increase to $4.9 million for the nine months ended September 30, 2026, compared to $2.2 million in the prior year, driven by product sales and distribution fees. Despite the growth, the company remains in a stockholders' deficit and continues to rely on debt financing, including $1.175 million in net proceeds from notes payable issued during 2026.

Key figure
Net loss $425K
5:17 PM ET 8-K
Leadership Change Douglas Elliman Inc. DOUG

Douglas Elliman Leadership Change

Douglas Elliman announced a major leadership transition including the retirement of CFO James B. Kirkland III and the departure of General Counsel Bradley H. Brodie. Heather Capriola, previously VP of Finance, has been appointed as the new Executive Vice President, Treasurer, and CFO. The departing executives will receive severance packages including cash payments and accelerated vesting of restricted shares.

5:17 PM ET 8-K
Nasdaq/NYSE Compliance Notice Datavault AI Inc. DVLT

Datavault AI Nasdaq/NYSE Compliance Notice

Datavault AI received a delisting notice from Nasdaq due to non-compliance with the $1.00 minimum bid price requirement and a closing bid price below $0.10 for ten consecutive business days. Trading on Nasdaq will be suspended effective November 17, 2026, at which point the company expects its common stock to begin trading on the OTC Markets. The company intends to request a hearing before the Nasdaq Hearings Panel to present a compliance plan and seek an extension to maintain its listing.

Counterparty
Nasdaq
5:17 PM ET 10-Q
Financial Results Nuvve Holding Corp. NVVE

Nuvve Holding Q3 2026 Results: Net Loss of $4.26M, Loss Narrows

Nuvve Holding Corp. reported a total revenue of $1.09 million for the quarter ended September 30, 2026, down from $1.60 million in the prior year period. The company experienced a net loss of $4.69 million for the quarter, contributing to a total stockholders' deficit of $13.42 million as of September 30, 2026.

Key figure
Net loss $4.26M
5:16 PM ET 8-K
Financial Results Cheetah Net Supply Chain Service Inc. CTNT

Cheetah Net Supply Chain Service Financial Results

Cheetah Net Supply Chain Service reported Q3 2026 revenue of $3.56 million, an 883% increase year-over-year driven by its international trading business acquisition. Despite the revenue growth, the company reported a net loss from continuing operations of $2.55 million, primarily due to a $2.78 million non-cash loss from the change in fair value of acquisition-related contingent consideration.

Term
Q3 2026

“The third quarter of 2026 marked an important step forward in the execution of our business diversification strategy. Following the acquisition of Super International Trading Limited in May, our international trading business demonstrated encouraging momentum, generating approximately $3.56 million in revenue during the quarter.”

Tony Liu, Cheetah’s Chairman and CEO

“Looking ahead, we remain committed to disciplined capital allocation, prudent financial management, and the pursuit of strategic opportunities that complement our existing capabilities.”

Tony Liu, Cheetah’s Chairman and CEO
5:16 PM ET 8-K
Shareholder Meeting Azio AI Holdings, Inc. AZIO

Azio AI Holdings Shareholder Meeting

Azio AI Holdings held its 2026 Annual Meeting where stockholders approved the 2026 Equity Incentive Plan and several other proposals. The meeting was adjourned until December 4, 2026, specifically to address Proposal 4 regarding the issuance of common stock upon conversion of Series A Preferred Stock, pending Nasdaq listing application approval. Approximately 54.2% of outstanding shares were represented at the meeting, constituting a quorum.

5:15 PM ET 10-Q
Financial Results CaliberCos Inc. CWD

CaliberCos Q3 2026 Results: Net Loss of $5.03M, Loss Widens

CaliberCos Inc. reported a net loss of $18.0 million for the nine months ended September 30, 2026, compared to a $15.0 million loss in the prior year period. Total assets increased significantly to $178.9 million from $135.4 million at year-end 2025, primarily driven by the consolidation of new investment funds and real estate assets.

Key figure
Net loss $5.03M
5:15 PM ET 8-K
Capital Raise Airwa Inc. YYAI

Airwa Capital Raise of $1.5M

AiRWA Inc. entered into securities purchase agreements with certain investors to sell 1,800,000 shares of common stock at $0.8332 per share. The transaction is expected to generate gross proceeds of approximately $1.5 million for working capital and general corporate purposes. The offering was conducted as a private placement in reliance on Section 4(a)(2) and Regulation D.

Value
$1.5M
5:15 PM ET 10-Q
Financial Results Cumberland Pharmaceuticals Inc CPIX

Cumberland Pharmaceuticals Q3 2026 Results: Turns Profitable, Net Income $77.8M

Cumberland Pharmaceuticals reported a significant net income of $77.8 million for the quarter ended September 30, 2026, primarily driven by an $81.1 million gain from the disposal of discontinued operations. Total revenue from continuing operations increased to $2.2 million, while the company declared a substantial cash dividend of $22.5 million during the period.

Key figure
Net income $77.8M
5:15 PM ET Form 4
Insider Selling Cricut, Inc. CRCT

Cricut CEO Arora Ashish Sells $1.83M of Stock

Arora Ashish, CEO, sold 210,000 shares of Cricut, Inc. at $8.58 to $8.95 a share (average $8.72) in 3 transactions, worth $1.83M in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 4,698,740 (-1.5%).

Value
$1.83M
Shares
210,000
Average price
$8.72
Role
CEO
Holding change
-1.5%
Trade date
Nov 11, 2026 to Nov 13, 2026
5:15 PM ET 8-K
Financial Results Where Food Comes From, Inc. WFCF

Where Food Comes From Financial Results

Where Food Comes From reported Q3 2026 total revenue of $7.3M, up 4% year-over-year, driven by 6% growth in its core verification and certification business. Operating income grew 68% to $1.0M as gross margins expanded to 42.1% due to cost-reduction initiatives and service bundling. The company also returned $268,000 to shareholders through stock buybacks during the quarter.

Term
Q3 2026

“We are pleased to report strong third quarter financial results highlighted by 6% growth in our core verification and certification business that is benefitting from resurgent demand for beef-related services and growing momentum in other service offerings.”

John Saunders, Chairman and CEO

“Our profit metrics also showed continued strength with gross margins rising by 380 basis points to 42.1% and operating income growing 68% to $1.0 million from $600,000 a year ago – both reflecting the positive impact of our ongoing cost down initiatives in conjunction with accelerating revenue.”

John Saunders, Chairman and CEO
5:15 PM ET 10-Q
Financial Results Research Alliance Corp IV RACD

Research Alliance Corp IV Q3 2026 Results: Net Income $379K

Research Alliance Corp IV reported a net income of $379,042 for the quarter ended September 30, 2026, primarily driven by $534,815 in interest earned on marketable securities held in the Trust Account. As a shell company, its activities are focused on identifying a target for a business combination, with $75,534,815 currently held in trust for its Class A ordinary shares.

Key figure
Net income $379K
5:14 PM ET 10-Q
Financial Results CIM Opportunity Zone Fund, L.P.

CIM Opportunity Zone Fund Q3 2026 Results: Net Income $7.87M, Up 42.0% YoY

CIM Opportunity Zone Fund, L.P. reported a net loss of $44.8 million for the nine months ended September 30, 2026, compared to a net income of $110.8 million in the prior year period. The decline was primarily driven by the absence of a $117.4 million realized gain on a lease investment recorded in 2025 and increased operating and interest expenses.

Key figure
Net income $7.87M · +42.0% YoY
5:14 PM ET Form 4
Insider Selling Korro Bio, Inc. KRRO

Korro Bio Director Jean Francois Formela Sells $964K of Stock

Jean Francois Formela, Director, sold 66,015 shares of Korro Bio, Inc. at $14.30 to $15.60 a share (average $14.60) in 5 transactions, worth $964K in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 121,219 (-5.4%).

Value
$964K
Shares
66,015
Average price
$14.60
Role
Director
Holding change
-5.4%
Trade date
Nov 11, 2026 to Nov 12, 2026
5:13 PM ET 10-Q
Financial Results DataMeds AI, Inc. MEDS

DataMeds AI Q3 2026 Results: Turns Profitable, Net Income $10.6M

DataMeds AI, Inc. (formerly Wellgistics Health, Inc.) reported a net income of $10.5 million for the quarter ended September 30, 2026, primarily driven by a $19.1 million gain on debt extinguishment. However, the company experienced a significant decline in nine-month revenues from $21.7 million in 2025 to $6.0 million in 2026, resulting in a year-to-date net loss of $15.6 million.

Key figure
Net income $10.6M
5:13 PM ET 8-K
Loan & Debt Booking Holdings Inc. BKNG

Booking Holdings Debt Financing Update with U.S. Bank Trust Company, National Association

Booking Holdings Inc. entered into an indenture for the sale of €1.25 billion in aggregate principal amount of senior notes. The transaction was executed via four Officers' Certificates under a base indenture with U.S. Bank Trust Company as trustee. The filing discloses the creation of a direct financial obligation related to these senior notes.

Counterparty
U.S. Bank Trust Company, National Association

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.